Rinvoq®

Active substance upadacitinib
Holder Abbvie
Status closed
Indication treatment of adults with severe Ankylosing Spondylitis who have no other suitable treatment option and are not eligible to participate in a clinical study.
Public documents Approbation
 

Information for the patient

  Informed consent
Last update 10/08/2022

 

Last updated on 13/02/2024